Healthcare Triangle, Inc.

What they do

The company provides IT and data services to the Healthcare and Life Sciences (HCLS) industry, formed in 2019 and operating since January 1, 2020, after SecureKloud Technologies Inc. transferred its Life Sciences business. Offerings include electronic health record (EHR) implementation and optimization, application managed services, cloud hosting, backup and disaster recovery, data engineering, and advanced analytics. As of June 30, 2026, it had 40 full-time employees and 27 sub-contractors, including 32 certified cloud engineers, 22 Epic-certified and 9 MEDITECH-certified EHR experts.

Revenue drivers

• AI powered Customer Engagement — The company states the majority of revenue is generated by this segment following the effective January 1, 2026 acquisitions of Teyame 360 S.L. and Datono Mediacion S.L.
• Software Services — Strategic advisory, implementation and development services delivered by full-time employees to healthcare and life sciences clients.
• Managed Services and Support — Post-implementation support and cloud hosting, including 24x7 managed services used by hospitals, health systems, payers, life sciences and biotech organizations.
• EHR implementation and optimization — EHR software implementation, optimization and extension to community partners, backed by Epic and MEDITECH certified staff.

Recent performance

Annual revenue fell from $45.9M in 2022 to $33.2M in 2023, $11.7M in 2024 and $13.9M in 2025, while net losses were $8.7M, $6.0M and $9.5M respectively. Operating cash flow was negative in each year shown, including -$16.5M in 2025 versus -$1.1M in 2024. Quarterly revenue was $3.5M in the September 2025 quarter and $3.1M in the December 2025 quarter, then jumped to $9.9M in the March 2026 quarter and $9.2M in the June 2026 quarter. At June 30, 2026, total assets were $73.6M, total liabilities $24.5M, shareholder equity $49.1M, cash and equivalents $1.9M, and long-term debt $8.1M.

Strategy

The company describes itself as focused on cloud services, data science, and professional and managed services for healthcare and life sciences, delivered through proprietary platforms and intellectual property as a service. The January 1, 2026 acquisitions of Teyame 360 S.L. and Datono Mediacion S.L. created the AI powered Customer Engagement segment, which management says now generates the majority of revenue. The company effected a 1-for-60 reverse split of its common stock on February 10, 2026. The 10-K/A filed April 16, 2026 amended only the audit report signature, leaving the financial statements unchanged.

Risks

• Revenue decline — Annual revenue fell from $45.9M in 2022 to $11.7M in 2024 and $13.9M in 2025, with quarterly revenue of $3.1M-$3.5M in late 2025 before the 2026 acquisition-driven increase.
• Persistent losses and cash burn — Net losses occurred in every year shown and operating cash flow was -$16.5M in 2025 versus -$1.1M in 2024.
• Liquidity — Cash and equivalents were $1.9M at June 30, 2026 against $24.5M of total liabilities and $8.1M of long-term debt.
• Dependence on new acquisitions — The company states the majority of revenue now comes from the Teyame and Datono businesses acquired effective January 1, 2026, making results dependent on a newly consolidated segment.

Outlook

The 10-Q MD&A discusses the company's approach to cloud, data science, and managed services for healthcare and life sciences and the role of the Teyame and Datono businesses in its revenue mix. The filings excerpted here do not provide specific numerical guidance for future periods.